Search

Search Constraints

You searched for: Author/Creator Trusolino, Livio

Search Results

2. Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial. Issue 6 (June 2016)

3. HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer. (5th April 2019)

4. INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases. Issue 4 (12th April 2019)

5. INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases. Issue 5 (24th May 2019)

6. Innovations, challenges, and minimal information for standardization of humanized mice. Issue 7 (24th June 2020)

7. MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients. (23rd January 2014)

8. Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial. Issue 5 (28th September 2020)

9. Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial. Issue 5 (28th September 2020)

10. Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial. Issue 5 (28th September 2020)